Standard Contracts
1 Exhibit 4.A SHARE PURCHASE AGREEMENT entered into in the Province of Quebec this 17th day of January, 1990.Share Purchase Agreement • July 28th, 1999 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • Quebec
AMENDMENT NO. 1 TO SHAREHOLDER AGREEMENTShareholder Agreement • April 19th, 2000 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • New York
2- 3 November 1, 1999 between the Guarantor and the Borrower and the Patent and Trademark Assignment and Security Agreement, dated November 1, 1999 between the Guarantor and the Borrower will each be terminated and the Borrower unconditionally and...Assignment Agreement • April 19th, 2000 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • New York
ARTICLE 2 REPRESENTATIONS AND WARRANTIESShare Purchase Agreement • August 2nd, 2000 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • Ontario
RECITALSShare Purchase Agreement • July 28th, 1999 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • Quebec
AMENDMENT TO TECHNOLOGY LICENSE AGREEMENT BY AND BETWEEN BIOCHEM PHARMA INC. AND CLINICHEM DEVELOPMENT INC.,Technology License Agreement • May 27th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances
1 EXHIBIT 1 NORTH AMERICAN VACCINE, INC. SUBSCRIPTION AGREEMENT, made as of this ___ day of _____, 1998 between North American Vaccine, Inc., a corporation organized under the laws of Canada (the "Company"), and the undersigned (the "Subscriber")....Subscription Agreement • December 9th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • New York
1 EXHIBIT 10.6 EXECUTION COPY AMENDMENT TO EXECUTION COPY RESEARCH AND DEVELOPMENT AGREEMENT BY AND BETWEEN BIOCHEM PHARMA INC. AND CLINICHEM DEVELOPMENT INC., THIS AMENDMENT (the "Amendment"), made and entered into as of the 4th day of May, 1998 (the...Research and Development Agreement • May 6th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances
1 EXHIBIT 1 STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENT, dated November 17, 1999, between Baxter International Inc., a Delaware corporation ("Acquisition"), and BioChem Pharma Inc. (the "Seller"). WHEREAS, the Seller owns 11,179,114 Common...Stock Purchase Agreement • November 23rd, 1999 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • New York
NORTH AMERICAN VACCINE, INC. 4.5% CONVERTIBLE SECURED NOTE DUE 2003Security Agreement • December 9th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances
RECITALSServices Agreement • March 24th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • Quebec
RECITALSResearch and Development Agreement • March 24th, 1998 • Biochem Pharma Inc • In vitro & in vivo diagnostic substances • Quebec
